Ocular Therapeutix
OCUL
#5706
Rank
C$1.84 B
Marketcap
C$8.40
Share price
-1.35%
Change (1 day)
-50.55%
Change (1 year)

Earnings for Ocular Therapeutix (OCUL)

Earnings in 2026 (TTM): -C$0.43 Billion

According to Ocular Therapeutix's latest financial reports the company's current earnings are C$52.05 Million. In 2025 the company made an earning of -C$0.39 Billion a decrease over its 2024 earnings that were of -C$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ocular Therapeutix from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.43 Billion10.22%
2025 -C$0.39 Billion37.43%
2024 -C$0.28 Billion139.68%
2023 -C$0.12 Billion13.65%
2022 -C$0.11 Billion984.05%
2021 -C$9.4 Million-95.79%
2020 -C$0.23 Billion80.19%
2019 -C$0.13 Billion44.01%
2018 -C$86 Million-5.38%
2017 -C$90.89 Million41.79%
2016 -C$64.1 Million12.47%
2015 -C$57 Million38.75%
2014 -C$41.08 Million115.12%
2013 -C$19.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
SurModics
SRDX
-C$16.07 Million-96.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Anika Therapeutics
ANIK
-C$7.35 Million-98.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Intersect ENT
XENT
-C$0.24 Billion-46.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Haemonetics
HAE
C$0.25 B-158.70%๐Ÿ‡บ๐Ÿ‡ธ USA